ISRG vs MSFT: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Microsoft Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
VS
Microsoft Corporation Β· Technology
$372.20
+32.4% upside to fair value
High Conviction Grade A
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). MSFT trades at a lower forward P/E (22.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG MSFT
Current Price $451.29 $372.20
Fair Value Estimate $1,039.74 $493.00
Upside to Fair Value +130.4% +32.4%
Market Cap $160.3B $2,763.6B
Forward P/E 53.8x 22.0x
EV / EBITDA 40.5x 17.5x
Price / Sales 15.2x 9.1x
Price / FCF 64.3x 35.8x
Revenue Growth YoY +23.0% +14.9%
Gross Margin 66.3% 68.8%
Operating Margin 30.5% 45.6%
Return on Equity 17.0% 29.6%
Dividend Yield 0% 0.94%
FCF Yield 1.55% 2.8%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
MSFT β€” Microsoft Corporation
Microsoft is the world's largest software company, operating a three-pillar empire across cloud (Azure), productivity (Office 365/Teams), and personal computing (Windows/Xbox). Azure is the second-largest cloud platform globally with 24% market share and growing at 38-39% in constant currency, while Microsoft Cloud revenue crossed $168.9B in FY2025. The stock has dropped 33% from its highs to $37…
Accumulation Zones
Metric ISRG MSFT
Zone Low $779.81 $370.00
Zone High $883.78 $419.00
In Buy Zone? Yes Yes
← ISRG Research    MSFT Research β†’    All Research